Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Olema Pharmaceuticals (OLMA) Change in Cash (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Change in Cash data on record, last reported at $4.2 million in Q1 2026.

  • On a quarterly basis, Change in Cash rose 104.78% to $4.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.9 million, a 88.73% decrease, with the full-year FY2025 number at -$91.2 million, down 228.53% from a year prior.
  • Change in Cash reached $4.2 million in Q1 2026 per OLMA's latest filing, down from $13.0 million in the prior quarter.
  • Over the last five years, Change in Cash for OLMA hit a ceiling of $103.6 million in Q4 2024 and a floor of -$88.8 million in Q1 2025.
  • A 5-year average of $2.3 million and a median of $2.3 million in 2022 define the central range for Change in Cash.
  • On a YoY basis, Change in Cash climbed as much as 3519.36% in 2023 and fell as far as 1475.37% in 2023.
  • Tracing OLMA's Change in Cash over 5 years: stood at -$3.1 million in 2022, then crashed by 1475.37% to -$48.9 million in 2023, then soared by 311.98% to $103.6 million in 2024, then crashed by 87.41% to $13.0 million in 2025, then plummeted by 67.44% to $4.2 million in 2026.
  • Business Quant data shows Change in Cash for OLMA at $4.2 million in Q1 2026, $13.0 million in Q4 2025, and -$17.2 million in Q3 2025.